Ocular Inflammation and Pain Market Insights, Epidemiology, and Market Forecast 1
Ocular Inflammation and Pain Market Insights, Epidemiology, and Market Forecast

DelveInsight has launched a new report on  “Ocular Inflammation and Pain Market

 

Ocular Inflammation and Pain is the inflammation of the eye causing pain, it often results from an infection by viruses or bacteria. But inflammation of the eye can also be nonspecific. Ocular inflammation can be caused by a number of different etiological mechanisms. These include allergens, contact lens wear, trauma and dietary or lifestyle changes. While there are different “triggers” of ocular inflammation, they produce similar symptoms because all induce essentially the same immunological cascades. The “irritation” produced is caused by the induction of the interleukin system, immune cell recruitment and complement activation.

 

Get a free sample page-  https://www.delveinsight.com/sample-request/ocular-inflammation-and-pain-market

 

Ocular Inflammation and Pain Market: Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

 

Ocular Inflammation and Pain Key Players

  • Eyepoint Pharmaceuticals
  • Alcon Research
  • Oculis Pharma
  • Formosa Pharmaceuticals
  • And many others

 

Ocular Inflammation and Pain Drugs

  • Dexycu
  • Nepafenac
  • OCS-01
  • APP13007
  • And many others

 

Ocular Inflammation and Pain Treatment

Inflammation after cataract surgery, which can be persistent, remains an undesirable consequence despite many advances in surgical techniques. Although corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) have traditionally been used to treat inflammation, prophylactically as well as post-operatively, there are no established guidelines for the treatment of inflammation induced by cataract surgery. The long-term use of corticosteroids has raised safety concerns, especially with regard to elevated intraocular pressure (IOP).

This limitation of traditional corticosteroids led to the development of C-20 ester corticosteroids through retrometabolic drug design. This design modification allows the corticosteroid to be active at its site of action and then undergo predictable hydrolysis to inactive metabolites, resulting in reduced side effects. While corticosteroids are traditionally the therapy of choice for inflammation, their long-term use for managing ocular inflammation can produce significant adverse events.

 

Ocular Inflammation and Pain Market Insights

The mainstay of non-infectious uveitis treatment is corticosteroids, which are administered in three forms: topically, locally via sub-Tenon’s or intravitreal injection, and systemically. Immunomodulating drugs may be added to the corticosteroid regimen to eliminate the need for high doses of systemic steroids, or used alone as steroid-sparing agents when steroids are not tolerated. Pharmacological agents used as part of immunomodulatory therapy (IMT) can also have potential adverse events, and thus must be used by physicians who have had extensive experience in administering them.

Primarily, four steroids are available: prednisolone, fluorometholone, dexamethasone and medrysone. On the horizon are two new “soft” steroids that have good anti-inflammatory effect but are metabolized quickly, thus reducing side effects and the likelihood of raising intraocular pressure (IOP).

 

Ocular Inflammation and Pain Market Size

Expected launch of the pipeline therapies shall fuel the growth of the market during the forecast period, i.e., 2020–2030. The market size shall grow during the forecast period owing to the launch of upcoming therapies. The market size is expected to increase at a CAGR of XX during the study period.

 

Ocular Inflammation and Pain Report Scope

  • The report covers the descriptive overview of Ocular Inflammation and Pain, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Ocular Inflammation and Pain epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Ocular Inflammation and Pain are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Ocular Inflammation and Pain market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Ocular Inflammation and Pain market

 

Get a free sample page-  https://www.delveinsight.com/sample-request/ocular-inflammation-and-pain-market

 

Table of content

  1. Key Insights
  2. Executive Summary of Ocular Inflammation and Pain
  3. Competitive Intelligence Analysis for Ocular Inflammation and Pain
  4. Ocular Inflammation and Pain: Market Overview at a Glance
  5. Ocular Inflammation and Pain: Disease Background and Overview
  6. Patient Journey
  7. Ocular Inflammation and Pain Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Ocular Inflammation and Pain Treatment
  11. Marketed Products
  12. Emerging Therapies
  13. Ocular Inflammation and Pain: Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Ocular Inflammation and Pain
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

 

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Ocular Inflammation and Pain market
  • To understand the future market competition in the Ocular Inflammation and Pain market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Ocular Inflammation and Pain in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Ocular Inflammation and Pain market
  • To understand the future market competition in the Ocular Inflammation and Pain market

 

You can check our latest blogs- https://www.delveinsight.com/blog/ 

 

Contact us

Shruti Thakur

info@delveinsight.com

+91-9650213330

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/